Recent studies provide further evidence implicating PITX1 as a tumor suppressor that correlates with patient survival and metastasis in various parenchymal tumors, including gastric carcinoma, breast cancer, esophageal carcinoma, lung cancer, and osteosarcoma (17–22). This evidence concerns the gene PITX1 and breast carcinoma.